International Society of Oncology Pharmacy Practitioners

What International Society of Oncology Pharmacy Practitioners does

The International Society of Oncology Pharmacy Practitioners (ISOPP) is a global, non-profit professional membership society founded in 1996 that supports oncology pharmacy practitioners across 125+ countries. The organization offers no-fee membership to 3,500+ practitioners worldwide and provides access to a centralized Virtual Education Resource Library ("The Library"), the peer-reviewed Journal of Oncology Pharmacy Practice (JOPP), monthly newsletters, webinars, Standards of Practice documents, toolkits, and a research mentorship program. ISOPP operates an annual International Symposium, with the 2026 edition marking its 30th anniversary as a 24-hour continuous virtual event featuring regional host blocks in Brisbane, Nairobi, Dublin, and Vancouver to enable global participation across all major time zones.

ISOPP's core technology is its virtual education platform and 24/7 resource library, which delivers searchable educational content including webinars, position statements, toolkits, and peer-reviewed publications. The society publishes a structured portfolio of educational programs developed in collaboration with national oncology pharmacy associations and pharmaceutical sponsors: the OPAB biosimilars program (Pfizer-supported), the UTIC targeted therapies course (joint with BOPA, supported by Roche Products Limited and Incyte Biosciences UK), the PAD anti-cancer drug course (with eviQ Education / Cancer Institute NSW), the Safe Handling Program for systemic anti-cancer therapy, the Breast Cancer Education Bundle (with CPA), and the CPD Bites video series (with FIP). Distribution is conducted through digital self-serve channels, a six-platform social media presence (LinkedIn, Facebook, Instagram, X, WhatsApp, Bluesky), and partnerships with national oncology pharmacy organizations including BOPA, CAPhO, HOPA, COSA, and others.

ISOPP generates revenue primarily through educational grants and sponsorship from pharmaceutical companies (Pfizer, AstraZeneca Gulf, Roche, Incyte), modest symposium registration fees, and voluntary donations. The society maintains no-fee membership as a deliberate accessibility strategy, with operations supported financially by partners and supporters. The secretariat is managed from Vancouver, BC, through Sea to Sky (an MCI Company), and governance is provided by an elected Board and President (currently Netty Cracknell), with day-to-day operations executed through volunteer-led committees including Advocacy, Engagement and Communications, Education, Research, and Awards. Strategic positioning emphasizes advocacy at global health bodies, including WHO Essential Medicines List participation and a UICC–ISOPP joint statement on quality and equity in cancer treatment focused on substandard anticancer medications in low- and middle-income countries.

Name

International Society of Oncology Pharmacy Practitioners

Legal name

International Society of Oncology Pharmacy Practitioners

Website

https://isopp.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

ISOPP is a global non-profit professional society founded in 1996 that supports 3,500+ oncology pharmacy practitioners across 125+ countries through no-fee membership, the Journal of Oncology Pharmacy Practice, the Library, and annual international symposia.

Ownership category

akta.pro rank

Headquarters

HQ city

North Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Dues: ISOPP currently offers no-fee membership, with financial support from partners and supporters to sustain operations
2. Symposium Registration Fees: Modest registration fee for annual international symposiums covering access to live and recorded sessions, virtual event platform, tech support, and networking tools
3. Educational Program Sponsorship: Pharmaceutical companies (Pfizer, AstraZeneca, Roche, Incyte) provide educational grants and sponsorship for specific programs including OPAB, UTIC, PAD Course, and GCC Course
4. Donations: Voluntary contributions from members and supporters to fund collaboration, educational programs, research mentorship, publishing, and access to Journal of Oncology Pharmacy Practice

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

ISOPP is a professional membership society that supports oncology pharmacy practitioners worldwide through no-fee membership. It delivers educational programs (online courses, webinars, masterclasses), peer-reviewed publications (Journal of Oncology Pharmacy Practice), annual international symposia, standards of practice, and a virtual education resource library. The society focuses on advancing oncology pharmacy care for individuals affected by cancer globally, with members in 125+ countries.

Product overview

ISOPP operates as a professional society offering a unified platform of member services, publications, and educational programs for oncology pharmacy practitioners worldwide. The core offerings include the Journal of Oncology Pharmacy Practice (JOPP) peer-reviewed journal, annual International Symposia (including virtual 24-hour formats), and the Research Mentorship Program. Educational portfolio comprises the OPAB Program on biosimilars, UTIC Course on targeted therapies and immunotherapies, PAD Course on anti-cancer drugs, Safe Handling Program for SACT/cytotoxic agents, CPD Bites with FIP video series, and Breast Cancer Education Bundle with CPA. The Library serves as the central 24/7 virtual resource hub for all member-accessible content. All resources are available at no-fee membership, with the organization claiming over 3,500 oncology pharmacy practitioners worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Journal of Oncology Pharmacy Practice (JOPP): Peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer
• Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program
• Pharmacy Anti-cancer Drug (PAD) Course
• UTIC (Understanding targeted therapies and immunotherapies for cancer)
• Safe Handling Program

Products and services

• Journal of Oncology Pharmacy Practice (JOPP)
• ISOPP International Symposium
• Research Mentorship Program
• The Library (Virtual Education Resource Library)
• Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program
• UTIC (Understanding Targeted Therapies and Immunotherapies for Cancer) Course
• Pharmacy Anti-cancer Drug (PAD) Course
• Safe Handling Program
• CPD Bites with FIP
• Breast Cancer Education Bundle
• GCC Course Online Learning Series
• ISOPP Webinars
• Masterclasses

Quantifiable outcome

• Over 3,500 oncology pharmacy practitioners supported globally
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

20 partnerships are on record, tiered core, major, flagship and minor.

• British Oncology Pharmacy Association (BOPA)coreStrategic or Co-development PartnerUK national oncology pharmacy association collaborating on education, safe handling programs (UTIC course), and professional development. BOPA is part of the ISOPP Global Oncology Pharmacy Leaders network and endorses ISOPP joint statements.
• Canadian Association of Pharmacy in Oncology (CAPhO)coreStrategic or Co-development PartnerLeading Canadian oncology pharmacy association co-hosting annual joint symposiums with ISOPP (e.g., ISOPP CAPhO 2025 Symposium). Active collaboration on education and professional standards.
• Hematology/Oncology Pharmacy Association (HOPA)coreStrategic or Co-development PartnerUS-based oncology pharmacy association collaborating on education and advocacy. HOPA has endorsed the UICC & ISOPP Joint Statement on quality and equity in cancer treatment.
• GEDEFO-SEFH (Spanish Society of Hospital Pharmacists)majorStrategic or Co-development PartnerOncology pharmacy working group of the Spanish Society of Hospital Pharmacists. Endorses ISOPP joint statements and participates in Global Oncology Pharmacy Leaders network.
• Irish Pharmacy Haematology Oncology Society (IPHOS)majorStrategic or Co-development PartnerIrish national society for hematology and oncology pharmacy. Endorsed the UICC & ISOPP Joint Statement and participates in global collaboration efforts.
• Union for International Cancer Control (UICC)flagshipStrategic or Co-development PartnerGlobal cancer control organization with which ISOPP issued a joint statement on ensuring quality and equity in cancer treatment. Focus on substandard anticancer medications in LMICs and regulatory capacity strengthening.
• International Pharmaceutical Federation (FIP)flagshipStrategic or Co-development PartnerGlobal pharmacy federation leading World Pharmacists Day campaign which ISOPP supports annually. Joint CPD Bites program on cancer care launched February 4, 2026 featuring practice-oriented videos for pharmacists.
• Commonwealth Pharmacists Association (CPA)majorStrategic or Co-development PartnerCollaboration on Breast Cancer Education Bundle - a 12-month program with webinars, resources, self-paced modules, and discussion forum for pharmacists new to oncology practice.
• AstraZeneca GulfmajorGTM or Marketing PartnerPharmaceutical company supporting GCC Course Online Learning Series for clinical pharmacists in Saudi Arabia, UAE and Gulf countries on recent oncology trends and international standards.
• Saudi Oncology Pharmacy Assembly (SOPA)majorStrategic or Co-development PartnerNational oncology pharmacy assembly in Saudi Arabia collaborating with AstraZeneca Gulf and ISOPP on Gulf Cooperation Council educational courses.
• Roche Products Limited and Incyte Biosciences UK LtdmajorGTM or Marketing PartnerPharmaceutical companies providing partial grant support for UTIC (Understanding Targeted Therapies and Immunotherapies for Cancer) education program - a joint ISOPP and BOPA collaboration.
• eviQ Education / Cancer Institute NSWmajorStrategic or Co-development PartnerAustralian cancer education platform collaborating with ISOPP on Pharmacy Anti-cancer Drug (PAD) Course for pharmacist training on anti-cancer drugs.
• PfizermajorGTM or Marketing PartnerPharmaceutical company providing educational grant to support the Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) program for oncology pharmacists.
• Moroccan Association for Research and Training in Oncological Pharmacy (AMRFPO)majorStrategic or Co-development PartnerMoroccan oncology pharmacy association committed to advancing oncology pharmacy in Africa through research, training, and international collaboration.
• Pakistan Society of Health-System Pharmacists (PSHP)majorStrategic or Co-development PartnerPakistani pharmacy organization with oncology focus, actively participating in Global Oncology Pharmacy Leaders and endorsing ISOPP joint statements.
• Oncology Pharmacists Society of Kenya (OPSoK)majorStrategic or Co-development PartnerKenyan national oncology pharmacy society actively involved in ISOPP Global Oncology Pharmacy Leaders network and quality initiatives.
• Clinical Oncology Society of Australia (COSA)majorStrategic or Co-development PartnerAustralian multi-disciplinary cancer organization with cancer pharmacists group, endorsing ISOPP joint statements and participating in global collaboration.
• Society for Oncology Pharmacy (SOCHIFO Chile)minorStrategic or Co-development PartnerChilean oncology pharmacy society participating in ISOPP Global Oncology Pharmacy Leaders network.
• Taiwan Hematology and Oncology Pharmacy AssociationminorStrategic or Co-development PartnerTaiwan national oncology pharmacy association participating in ISOPP Global Oncology Pharmacy Leaders network.
• French Society for Oncology Pharmacy (SFPO)minorStrategic or Co-development PartnerFrench national oncology pharmacy society endorsing UICC & ISOPP Joint Statement on quality and equity in cancer treatment.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• National Comprehensive Cancer Network (NCCN): US-based oncology standards body whose Drugs & Biologics Programs are led by ISOPP's immediate past president. NCCN's clinical practice guidelines include pharmacy-relevant content and represent a broader incumbent in oncology standards and education.
• European Society for Medical Oncology (ESMO): Leading European professional organization for medical oncology. While focused on physician oncologists rather than pharmacists, ESMO overlaps with ISOPP in cancer education, multidisciplinary care, and influence over oncology practice standards globally.
• American Society of Health-System Pharmacists (ASHP): Large US-based professional society for hospital and health-system pharmacists, including oncology pharmacy. Overlaps with ISOPP on safe handling of hazardous drugs and pharmacy practice standards, but covers all pharmacist specialties rather than oncology specifically.
• International Pharmaceutical Federation (FIP): Global federation representing the entire pharmacy profession across all specialties. ISOPP partners with FIP on the CPD Bites video series and World Pharmacists Day. FIP is a broader incumbent with overlapping educational mission but no oncology pharmacy specialization.

Others

• Commonwealth Pharmacists Association (CPA): Pharmacy association serving Commonwealth countries, co-developing the Breast Cancer Education Bundle with ISOPP. CPA focuses on broader pharmacy capacity building across the Commonwealth while ISOPP brings oncology specialization to the partnership.
• Union for International Cancer Control (UICC): Global cancer control umbrella organization that co-issued the Joint Statement with ISOPP on quality and equity in cancer treatment. A partner organization rather than a competitor; UICC's broader cancer-control mission complements ISOPP's oncology pharmacy focus.

Direct peers

• Hematology/Oncology Pharmacy Association (HOPA): US-based professional association for oncology pharmacists that collaborates directly with ISOPP on education, advocacy, and joint statements (e.g., UICC & ISOPP Joint Statement endorsement). HOPA serves the same oncology pharmacy practitioner persona but is geographically focused on the US.
• French Society for Oncology Pharmacy (SFPO): French national oncology pharmacy society endorsing ISOPP joint statements and participating in Global Oncology Pharmacy Leaders. Same oncology pharmacy practitioner focus, French geographic scope.
• British Oncology Pharmacy Association (BOPA): UK national oncology pharmacy association co-developing the UTIC course with ISOPP and participating in the Global Oncology Pharmacy Leaders network. BOPA is a direct peer: same member base, same content focus, but country-scoped.
• Canadian Association of Pharmacy in Oncology (CAPhO): Leading Canadian oncology pharmacy association that co-hosts joint symposia with ISOPP (e.g., ISOPP CAPhO 2025). Directly comparable mission and member persona, scoped to Canada.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ISOPPorg
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/international-society-of-oncology-pharmacy-practitioners-isopp
• Instagraminstagram.com/isoppinsta

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Society of Oncology Pharmacy Practitioners